Walter & Keenan Wealth Management LLC IN ADV Acquires 71 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Walter & Keenan Wealth Management LLC IN ADV increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 609 shares of the medical equipment provider’s stock after purchasing an additional 71 shares during the period. Walter & Keenan Wealth Management LLC IN ADV’s holdings in Intuitive Surgical were worth $302,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after purchasing an additional 360,591 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after purchasing an additional 243,802 shares in the last quarter. Fisher Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Norges Bank bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $2,401,493,000. Finally, Invesco Ltd. lifted its holdings in shares of Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock valued at $2,165,184,000 after purchasing an additional 295,025 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $509.49 on Friday. The stock’s fifty day moving average price is $527.71 and its two-hundred day moving average price is $537.69. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The firm has a market cap of $182.61 billion, a price-to-earnings ratio of 74.71, a P/E/G ratio of 5.40 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the prior year, the company posted $1.50 EPS. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the company’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares in the company, valued at $3,312,920. This represents a 27.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president now owns 907 shares of the company’s stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ISRG has been the topic of several recent analyst reports. Evercore ISI cut their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a report on Wednesday, April 23rd. Piper Sandler cut their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research note on Monday, April 14th. Citigroup restated a “buy” rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Finally, Barclays cut their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.